Edmund E Marinelli

Title: The Innovations of Edmund E Marinelli

Introduction

Edmund E Marinelli is a notable inventor based in Lawrenceville, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the development of compounds that have potential applications in medical diagnostics and treatment.

Latest Patents

Marinelli holds a patent for "Linkable sialyl Lewis X analogs." This patent discloses a class of linkable tetrasaccharide compounds, including the amino phenyl glycoside of sialyl Lewis X (SLe) and related analogs. These compounds feature conjugatable nucleophilic groups, which make them useful for preparing multimeric SLe compositions. The disclosed SLe compounds can be utilized to create selectin binding ligand conjugates by linking them to various reporter moieties, such as contrast agents, radiodiagnostic agents, or cytotoxic and chemotherapeutic agents. The SLe compounds and conjugates exhibit binding to selectin that is comparable to native Sialyl Le, making them valuable for diagnosing and treating selectin-mediated disorders and related conditions. Marinelli has 1 patent to his name.

Career Highlights

Edmund E Marinelli is associated with Bracco International Bv, a company known for its innovations in the field of medical imaging and diagnostics. His work at Bracco has allowed him to contribute to advancements that can significantly impact patient care and treatment options.

Collaborations

Throughout his career, Marinelli has collaborated with esteemed colleagues, including Ramachandran S Ranganathan and Kondareddiar Ramalingam. These collaborations have fostered an environment of innovation and have led to the development of groundbreaking technologies.

Conclusion

Edmund E Marinelli's contributions to the field of biochemistry and his innovative patent for linkable sialyl Lewis X analogs highlight his role as a significant inventor. His work continues to pave the way for advancements in medical diagnostics and treatment options.